Although we have confirmed through a series of in vitro experiments that the use of this demethylation system can effectively activate BRD7 expression, thereby exerting a significant tumour suppressor effect, the success of future clinical applications will largely depend on the safety and efficacy of this system. The gene discussed is BRD7; the disease is neoplasm.